12:00 AM
 | 
Mar 11, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Open Monoclonal Technology, WuXi sales and marketing update

The companies made Open Monoclonal's OmniRat mAb platform available at WuXi's Shanghai facility. WuXi's clients can choose to develop and commercialize products using OmniRat globally or regionally within Asia, and clients that choose...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >